Semaglutide in Florida — clinically proven GLP-1 weight loss, from $199/mo.
Compounded semaglutide prescribed online by Florida-licensed providers and shipped discreetly statewide. In the STEP 1 trial, adults lost an average of 14.9% of body weight over 68 weeks. Pay only if prescribed.

Compounded semaglutide, fully managed online.
Built for Floridians who want medical-grade weight loss without the pharmacy lines, the in-person appointments, or the surprise bills. One transparent monthly price. Real clinicians. Real results (STEP 1 trial, 2025 NEJM trial).
Florida-licensed care
Every visit is reviewed by a clinician licensed in the State of Florida — not a national call-center provider. Medical reviews led by Hilary Ortega, NP.
Clinically supported
Semaglutide is one of the most studied GLP-1 medications. A recent 2025 NEJM head-to-head compared semaglutide and tirzepatide directly for obesity.
Discreet statewide shipping
Plain, unmarked packaging delivered to any Florida address — Miami, Tampa, Orlando, Jacksonville, the Keys, and every ZIP in between.
Care that meets you where you are.
Three simple steps to start a treatment plan with a real clinician — entirely from home.
- 1
Take the quiz
Share your goals and history in a confidential 5-minute intake. No insurance, no waiting room.
- 2
Talk to a provider
A Florida-licensed clinician reviews your case and, if appropriate, prescribes a personalized plan.
- 3
Get your meds shipped
Treatment ships free in discreet packaging. Ongoing check-ins and available messaging included.
Semaglutide isn't right for everyone
Compare your options.
Decide between semaglutide, tirzepatide, and supporting peptides.
Cities we serve
Florida-licensed telehealth from semaglutide and tirzepatide to ketamine therapy and peptides — shipped to your door across the state.
Start semaglutide today, from anywhere in Florida.
5-minute online quiz. Florida-licensed provider review. Discreet shipping. From $199/mo — pay only if prescribed.
Scientific References
Peer-reviewed studies (2021 and newer) referenced on this page.
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002.
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216.
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. N Engl J Med. 2025.